Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →24
🟡 Moderate
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,569
Total Claims
$817K
Drug Cost
421
Beneficiaries
$1,941
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+46%
Opioid rate vs peers
3.8% vs 2.6% avg
+82%
Cost per patient vs peers
$1,941 vs $1,068 avg
+39%
Brand preference vs peers
12.5% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
3.8%
Opioid Rate
322
Opioid Claims
$3,512
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,056 claims · $696K
Generic: 7,404 claims · $116K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 111 | $147K |
| Empagliflozin | 95 | $106K |
| Apixaban | 90 | $81K |
| Fluticasone/Umeclidin/Vilanter | 51 | $45K |
| Insulin Glargine,hum.Rec.Anlog | 56 | $37K |
| Linagliptin | 24 | $25K |
| Tiotropium Bromide | 31 | $22K |
| Sitagliptin Phosphate | 18 | $20K |
| Insulin Glargine/Lixisenatide | 15 | $19K |
| Insulin Degludec | 14 | $15K |
| Insulin Glargine,hum.Rec.Anlog | 13 | $12K |
| Fluticasone Propion/Salmeterol | 39 | $9,943 |
| Insulin Glargine,hum.Rec.Anlog | 12 | $8,462 |
| Fluticasone/Vilanterol | 12 | $8,448 |
| Insulin Detemir | 21 | $7,122 |
Prescribing Profile
Patient Profile
72
Avg Age
77%
Female
1.36
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About